Arch Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
0.000.000.000.00
Price/Sales ratio
N/AN/AN/AN/A
Earnings per Share (EPS)
$10.39$15.13$1.56$1.94

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-1.49-7.31-13.78-14.84-12.68-14.65-8.12-4.35-1.07-0.57-125.41-14.65
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/A2.47K294.2952.7740.25KN/A
Price/Book Value ratio
-1.7614.0026.1251.9244.92-49.45-21.71-27.88-1.09-0.53-117.68-49.45
Price/Cash Flow ratio
-3.62-5.08-17.39-20.58-10.32-7.57-6.45-4.79-1.03-1.18-176.44-7.57
Price/Free Cash Flow ratio
-3.62-5.08-17.39-20.55-10.30-7.57-6.45-4.79-1.03-1.18-176.44-7.57
Price/Earnings Growth ratio
-0.030.10-0.37-1.400.300.30-0.26-0.100.020.01-0.030.30
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/A-127.25%-228.96%-3.22%-203.95%N/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/A-55141.58%-36473.33%-6661.66%-31798.40%N/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/A-53960.06%-33707.21%-9221.43%-32094.80%N/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/A-56802.78%-27318.25%-9221.43%-32094.80%N/A
Effective Tax Rate
-1.36%-12.80%96.35%-0.67%-54.75%40.11%14.47%-5.26%18.95%N/AN/A-54.75%
Return on Assets
-928.49%-73.63%-116.48%-127.89%-99.46%-93.83%-186.52%-178.68%-164.21%-356.59%-113209.64%-93.83%
Return On Equity
118.14%-191.38%-189.57%-349.82%-354.01%337.34%267.38%640.48%101.98%93.00%128.83%-354.01%
Return on Capital Employed
249.73%-200.98%-185.29%-129.09%-163.67%-291.16%-356.90%-327.21%796.47%67.19%132.23%-163.67%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.41N/A
Quick Ratio
0.323.112.7314.0216.713.561.811.480.350.060.003.56
Cash ratio
0.303.072.6813.8216.183.051.481.310.220.020.003.05
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/A-9.69K-10.17KN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/A15.35K51.01K15.19K10.02K6.37K9.84K15.35K
Operating Cycle
N/AN/AN/AN/AN/AN/AN/A5.49K-147.176.37K9.84KN/A
Days of Payables Outstanding
N/AN/AN/A64.53K10.99K23.64K18.02K5.66K9.41K10.76K12.28K10.99K
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/A-177.27-9.56K-4.38K-9.85KN/A
Debt Ratios
Debt Ratio
1.080.350.19N/AN/AN/A0.330.431.292.871.55KN/A
Debt Equity Ratio
-0.130.930.30N/AN/AN/A-0.48-1.55-0.80-0.74-1.29N/A
Long-term Debt to Capitalization
-0.160.380.02N/AN/AN/A-0.842.78-2.03N/A-0.87N/A
Total Debt to Capitalization
-0.160.480.23N/AN/AN/A-0.932.78-4.04-2.99-1.75N/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-5.20N/A
Cash Flow to Debt Ratio
-3.50-2.94-4.85N/AN/AN/A-6.94-3.72-1.32-0.59-1.04N/A
Company Equity Multiplier
-0.122.591.622.733.55-3.59-1.43-3.58-0.62-0.26-0.00-0.00
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/A-515.22-284.69-44.55-228.12N/A
Free Cash Flow / Operating Cash Flow Ratio
1111.001.0011.001.0011.0011
Cash Flow Coverage Ratio
-3.50-2.94-4.85N/AN/AN/A-6.94-3.72-1.32-0.59-1.04N/A
Short Term Coverage Ratio
N/A-8.94-5.27N/AN/AN/A-134.73N/A-8.10-0.59-3.92N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A